Opsonizing cancer cells with antibodies targeting specific proteins upregulated in tumors tags them for clearance by the complement system, phagocytes, and/or NK cells [287], rationalizing combinations of therapeutic antibodies with CD47 blockade. This evidence concerns the gene CD47 and cancer.